Digoxin Medulloblastoma Study

ClinicalTrials.gov ID: NCT06701812

Public ClinicalTrials.gov record NCT06701812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 2:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Digoxin for Relapsed Non-WNT, Non-SHH Medulloblastoma

Study identification

NCT ID: NCT06701812
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Enrollment: 23 participants

Conditions and interventions

Conditions

Interventions

Digoxin Drug

Drug

Eligibility (public fields only)

Age range: 12 Months to 30 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 14, 2026
Primary completion: Jan 31, 2027
Completion: Jan 31, 2027
Last update posted: Jul 6, 2026

2026 – 2027

United States locations

U.S. sites: 15
U.S. states: 11
U.S. cities: 15

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham Children's of Alabama	Birmingham	Alabama	35233	Recruiting
Arkansas Childrens Hospital	Little Rock	Arkansas	72202	Recruiting
Connecticut Children's Medical Center	Hartford	Connecticut	06106	Not yet recruiting
Children's National Medical Center	Washington D.C.	District of Columbia	20010	Not yet recruiting
Nemours Jacksonville	Jacksonville	Florida	32207	Not yet recruiting
University of Miami	Miami	Florida	33136	Not yet recruiting
Johns Hopkins All Children's	St. Petersburg	Florida	33701	Recruiting
St. Joseph's Children's Hospital	Tampa	Florida	33607	Recruiting
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center	Baltimore	Maryland	21218	Recruiting
Washington University St. Louis	St Louis	Missouri	63130	Recruiting
Montefiore Medical Center	The Bronx	New York	10467	Recruiting
UNC Lineberger Comprehensive Cancer Center	Chapel Hill	North Carolina	27514	Recruiting
Levine Cancer Institute	Charlotte	North Carolina	28204	Recruiting
Vanderbilt University Medical Center	Nashville	Tennessee	37232	Recruiting
UT Southwestern	Dallas	Texas	75390	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06701812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 6, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06701812 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →